The FDA has cleared an accelerated protocol for a transcranial magnetic stimulation system in the treatment of depression and ...

BrainsWay announced it received FDA clearance of an accelerated protocol for its deep transcranial magnetic stimulation (TMS) ...

Clinical data shows that BrainsWay’s new accelerated stimulation protocol is comparable to standard Deep TMS in depression ...

Under the new policy, nearly 1 million individuals with fee-for-service Medicaid and over 4.4 million individuals with Managed Care Organizations, will now be covered for TMS services by Medicaid in ...

Transcranial magnetic stimulation is an FDA-approved treatment for depression. A growing number of local clinics are offering the treatment.

Apollo TMS Therapy delivers targeted stimulation to specific brain regions responsible for mood and emotional regulation.The ...

Brainsway ( ($BWAY) ) has issued an update. On September 16, 2025, BrainsWay Ltd. announced that it received FDA clearance for an accelerated Deep ...

Individuals seeking a noninvasive treatment for depression, anxiety, or mental fog can find help at Precision Psychiatry in West Des Moines, Iowa. Precision Psychiatry, a practice delivering ...

The FDA clearance expands the acceptable protocols for BrainsWay's deep transcranial magnetic stimulation, a non-invasive treatment used to treat patients with major depressive disorder, including ...

Dr. Srini Pillay answers the question: 'Medications Causing Anxiety Disorders?' — -- Question: Can an anxiety disorder be associated with the use of certain medications? Answer: The sympathetic ...

BrainsWay (Nasdaq:BWAY) today announced the FDA granted expanded clearance for its Deep Transcranial Magnetic Stimulation ...